OBJECTIVE: The purpose of this study was to estimate which strategy is the most cost-effective for the prevention of preterm birth and associated morbidity. STUDY DESIGN: We used decision-analytic and cost-effectiveness analyses to estimate which of 4 strategies was superior based on quality-adjusted life-years, cost in US dollars, and number of preterm births prevented. RESULTS: Universal sonographic screening for cervical length and treatment with vaginal progesterone was the most cost-effective strategy and was the dominant choice over the 3 alternatives: cervical length screening for women at increased risk for preterm birth and treatment with vaginal progesterone; risk-based treatment with 17 alpha-hydroxyprogesterone caproate (17-OHP-C) without screening; no screening or treatment. Universal screening represented savings of $1339 ($8325 vs $9664), when compared with treatment with 17-OHP-C, and led to a reduction of 95,920 preterm births annually in the United States. CONCLUSION: Universal sonographic screening for short cervical length and treatment with vaginal progesterone appears to be cost-effective and yields the greatest reduction in preterm birth at <34 weeks' gestation. Copyright 2010 Mosby, Inc. All rights reserved.
OBJECTIVE: The purpose of this study was to estimate which strategy is the most cost-effective for the prevention of preterm birth and associated morbidity. STUDY DESIGN: We used decision-analytic and cost-effectiveness analyses to estimate which of 4 strategies was superior based on quality-adjusted life-years, cost in US dollars, and number of preterm births prevented. RESULTS: Universal sonographic screening for cervical length and treatment with vaginal progesterone was the most cost-effective strategy and was the dominant choice over the 3 alternatives: cervical length screening for women at increased risk for preterm birth and treatment with vaginal progesterone; risk-based treatment with 17 alpha-hydroxyprogesterone caproate (17-OHP-C) without screening; no screening or treatment. Universal screening represented savings of $1339 ($8325 vs $9664), when compared with treatment with 17-OHP-C, and led to a reduction of 95,920 preterm births annually in the United States. CONCLUSION: Universal sonographic screening for short cervical length and treatment with vaginal progesterone appears to be cost-effective and yields the greatest reduction in preterm birth at <34 weeks' gestation. Copyright 2010 Mosby, Inc. All rights reserved.
Authors: J C Carey; M A Klebanoff; J C Hauth; S L Hillier; E A Thom; J M Ernest; R P Heine; R P Nugent; M L Fischer; K J Leveno; R Wapner; M Varner Journal: N Engl J Med Date: 2000-02-24 Impact factor: 91.245
Authors: S S Hassan; R Romero; S M Berry; K Dang; S C Blackwell; M C Treadwell; H M Wolfe Journal: Am J Obstet Gynecol Date: 2000-06 Impact factor: 8.661
Authors: R L Goldenberg; J D Iams; A Das; B M Mercer; P J Meis; A H Moawad; M Miodovnik; J P VanDorsten; S N Caritis; G R Thurnau; M P Dombrowski; J M Roberts; D McNellis Journal: Am J Obstet Gynecol Date: 2000-03 Impact factor: 8.661
Authors: B M Mercer; R L Goldenberg; A H Moawad; P J Meis; J D Iams; A F Das; S N Caritis; M Miodovnik; M K Menard; G R Thurnau; M P Dombrowski; J M Roberts; D McNellis Journal: Am J Obstet Gynecol Date: 1999-11 Impact factor: 8.661
Authors: B M Mercer; R L Goldenberg; A Das; A H Moawad; J D Iams; P J Meis; R L Copper; F Johnson; E Thom; D McNellis; M Miodovnik; M K Menard; S N Caritis; G R Thurnau; S F Bottoms; J Roberts Journal: Am J Obstet Gynecol Date: 1996-06 Impact factor: 8.661
Authors: Paul J Meis; Mark Klebanoff; Elizabeth Thom; Mitchell P Dombrowski; Baha Sibai; Atef H Moawad; Catherine Y Spong; John C Hauth; Menachem Miodovnik; Michael W Varner; Kenneth J Leveno; Steve N Caritis; Jay D Iams; Ronald J Wapner; Deborah Conway; Mary J O'Sullivan; Marshall Carpenter; Brian Mercer; Susan M Ramin; John M Thorp; Alan M Peaceman; Steven Gabbe Journal: N Engl J Med Date: 2003-06-12 Impact factor: 91.245
Authors: Roberto Romero; Kypros Nicolaides; Agustin Conde-Agudelo; Ann Tabor; John M O'Brien; Elcin Cetingoz; Eduardo Da Fonseca; George W Creasy; Katharina Klein; Line Rode; Priya Soma-Pillay; Shalini Fusey; Cetin Cam; Zarko Alfirevic; Sonia S Hassan Journal: Am J Obstet Gynecol Date: 2011-12-11 Impact factor: 8.661
Authors: Lorene A Temming; Jennifer K Durst; Methodius G Tuuli; Molly J Stout; Jeffrey M Dicke; George A Macones; Alison G Cahill Journal: Am J Obstet Gynecol Date: 2016-02-10 Impact factor: 8.661
Authors: Laura T Pizzi; Neil S Seligman; Jason K Baxter; Eric Jutkowitz; Vincenzo Berghella Journal: Pharmacoeconomics Date: 2014-05 Impact factor: 4.981
Authors: Barbara L McFarlin; Viksit Kumar; Timothy A Bigelow; Douglas G Simpson; Rosemary C White-Traut; Jacques S Abramowicz; William D O'Brien Journal: Ultrasound Med Biol Date: 2015-08-08 Impact factor: 2.998